Compared with that at 24 h, CMTX at 6 h provided earlier warning of LP and guided the necessary prophylactic treatment (granulocyte colony-stimulating factor or mecapegfilgrastim), thus effectively preventing potentially life-threatening secondary infections. The gene discussed is CSF3; the disease is infection.